Vera Therapeutics to present at Bank of America 2026 Health Care Conference May 13

Vera Therapeutics, a biotech company developing treatments for serious immunological diseases, will present at the Bank of America Securities 2026 Health Care Conference in Las Vegas on May 13, 2026. The management team will also hold one-on-one investor meetings. Vera's lead product candidate, atacicept, targets autoimmune diseases like IgA nephropathy and lupus nephritis. The company is also developing other therapies including VT-109 and MAU868, focusing on B-cell mediated diseases and BK virus infection in kidney transplant patients. A replay of the presentation will be available for 90 days on Vera Therapeutics' website.